Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × daratumumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 117 Recurrence 9 Immunoglobulin Light-chain Amyloidosis 6 Neoplasms, Plasma Cell 5 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 4 Smoldering Multiple Myeloma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm, Residual 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Hematologic Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmacytoma 2 Acute Kidney Injury 2 Triple Negative Breast Neoplasms 1 Proteostasis Deficiencies 1 Primary Myelofibrosis 1 Plasmablastic Lymphoma 1 Non-small Cell Lung Cancer With STK11/LKB1 Mutation 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

pembrolizumab 226 Carboplatin 199 Pemetrexed 167 Cisplatin 118 Paclitaxel 107 Nivolumab 88 durvalumab 75 osimertinib 71 Docetaxel 69 Specimen Handling 54 atezolizumab 49 Magnetic Resonance Spectroscopy 48 Drug Therapy 47 Gemcitabine 44 Radiotherapy 41 Bevacizumab 36 Radiosurgery 35 cemiplimab 33 Ipilimumab 33 130-nm albumin-bound paclitaxel 32 tislelizumab 31 Cetuximab 23 Taxes 20 Immunotherapy 20 Immune Checkpoint Inhibitors 20 amivantamab 18 Platinum Compounds 18 Blood Specimen Collection 17 Biopsy 17 Surgical Procedures, Operative 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06015724 2025-07-28

DARANIVOVAX

Georgetown University

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡